1例前列腺癌膀胱壁复发患者68Ga-PSMA与18F-PSMA PET/CT的比较

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Molecular Imaging and Radionuclide Therapy Pub Date : 2023-06-20 DOI:10.4274/mirt.galenos.2023.47550

Çiğdem Soydal, Burak Demir, Gizem Sütçü, Mine Araz, Nuriye Özlem Küçük

{"title":"1例前列腺癌膀胱壁复发患者68Ga-PSMA与18F-PSMA PET/CT的比较","authors":"Çiğdem Soydal, Burak Demir, Gizem Sütçü, Mine Araz, Nuriye Özlem Küçük","doi":"10.4274/mirt.galenos.2023.47550","DOIUrl":null,"url":null,"abstract":"Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, 68Ga-prostate-specific membrane antigen (PSMA) or 18F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in 68Ga-PSMA positron emission tomography/computed tomography (PET/CT), 18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/62/MIRT-32-150.PMC10284183.pdf","citationCount":"0","resultStr":"{\"title\":\"Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.\",\"authors\":\"Çiğdem Soydal, Burak Demir, Gizem Sütçü, Mine Araz, Nuriye Özlem Küçük\",\"doi\":\"10.4274/mirt.galenos.2023.47550\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, 68Ga-prostate-specific membrane antigen (PSMA) or 18F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in 68Ga-PSMA positron emission tomography/computed tomography (PET/CT), 18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.\",\"PeriodicalId\":44681,\"journal\":{\"name\":\"Molecular Imaging and Radionuclide Therapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-06-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/62/MIRT-32-150.PMC10284183.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Molecular Imaging and Radionuclide Therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4274/mirt.galenos.2023.47550\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Radionuclide Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/mirt.galenos.2023.47550","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

前列腺癌是世界上最常见的癌症之一。根治性前列腺切除术后，前列腺特异性抗原(PSA)水平通常被用作前列腺癌复发的标志。在PSA水平升高的情况下，68ga -前列腺特异性膜抗原(PSMA)或18F-PSMA，一种新的替代方法，可用于检测复发性疾病。我们报告一例49岁男性患者，PSA水平升高，8年前曾做过手术。68Ga-PSMA正电子发射断层扫描/计算机断层扫描(PET/CT)未见明显病理性摄取，但18F-PSMA PET/CT显示膀胱壁上可见病理性摄取病变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

查看原文本刊更多论文

Comparison of ⁶⁸Ga-PSMA PET/CT and ¹⁸F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.

Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, ⁶⁸Ga-prostate-specific membrane antigen (PSMA) or ¹⁸F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in ⁶⁸Ga-PSMA positron emission tomography/computed tomography (PET/CT), ¹⁸F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Molecular Imaging and Radionuclide Therapy RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.